Intuitive Surgical: FY26 Q2 earnings call, Jul 16, 2026
No Kalshi or Polymarket word markets were listed for Intuitive Surgical’s Jul 16, 2026 earnings call (FY26 Q2). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
8 matches for “China”; 5 quoted, at least 25 words apart.
…Asia each up 20% and rest of world markets up 22%. In China, the environment remains challenging. We continue to see lower tender activity, increased…
da Vinci procedure growth in China and Japan was slightly ahead of the global average, but continued to be impacted by the market-specific dynamics we…
In China, we continue to face competitive dynamics, placing two systems, including our first da Vinci 5 system in Hong Kong. da Vinci 5 is…
…of changes to ACA premium subsidies and patient behavior in the U.S., China tender volumes and competitive intensity in that market, capital pressure in parts…
China is competitive and challenging from a pricing perspective. Japan has been impacted by government funding. We think the reimbursement decisions that went into effect…
Agents: this page as TSV at /api/v1/appearances/intuitive-surgical:2026-07-16:earnings_call · words: /api/v1/brief?appearance=intuitive-surgical:2026-07-16:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP